Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • BUSCOPAN® PLUS - Gastrointestinal Diseases
    Clinical Study Number 218.202
    Study Indication Gastrointestinal Diseases
    Product BUSCOPAN® PLUS
    Generic Name Hyoscine butylbromide + Paracetamol
    Lab Code
    Clinical Phase II
    Study Title

    Buscopan® plus, Buscopan®, paracetamol and placebo: Double-blind randomized group comparison to investigate the efficacy and tolerability of the film-coated tablets in patients with painful gastric or intestinal spasms

    Study Document
    Trial synopsis 218.202 english
  • JARDIANCE ® - Gastrointestinal Diseases
    Clinical Study Number 1245.8
    Study Indication Gastrointestinal Diseases
    Product JARDIANCE ®
    Generic Name Empagliflozin
    Lab Code
    Clinical Phase I
    Study Title

    A phase I, open-label, single-dose trial to investigate the metabolism and pharmacokinetics of 50 mg [14C]-BI 10773 when administered as oral solution to healthy male volunteers

    Study Document
    Trial synopsis 1245.8_CO english